Signifor and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Signifor (pasireotide diaspartate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Pantoprazole, and have Pituitary-dependent cushing's syndrome.

The phase IV clinical study analyzes which people have Weakness when taking Signifor. It is created by eHealthMe based on reports of 886 people who have side effects when taking Signifor from the FDA, and is updated regularly.

What is Signifor?

Signifor has active ingredients of pasireotide diaspartate. eHealthMe is studying from 887 Signifor users. Check the latest studies of Signifor.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 16, 2026

886 people reported to have side effects when taking Signifor.
Among them, 73 people (8.24%) have Weakness.

Among these 73 people:

How long have people been on Signifor when they have Weakness? *

What is the gender of people who have Weakness when taking Signifor? *

female: 84.06 %
male: 15.94 %

What is the age of people who have Weakness when taking Signifor? *

What are other drugs people take besides Signifor? *

What are other side effects people have besides Weakness? *

Nausea (feeling of having an urge to vomit): 50 people, 68.49%
Fatigue (feeling of tiredness): 47 people, 64.38%
Nausea And Vomiting: 37 people, 50.68%
Dizziness: 29 people, 39.73%
Headache (pain in head): 28 people, 38.36%
Diarrhea: 23 people, 31.51%
Pain: 22 people, 30.14%
Dyspnea (difficult or laboured breathing): 21 people, 28.77%
Peripheral Swelling: 19 people, 26.03%
Weight Increased: 19 people, 26.03%

What are the existing conditions these people have? *

Pituitary-Dependent Cushing's Syndrome (pituitary dependent hypercortisolism): 65 people, 89.04%
High Blood Pressure: 12 people, 16.44%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 9.59%
Hypokalemia (low potassium): 5 people, 6.85%
High Blood Cholesterol: 4 people, 5.48%
Cushing's Syndrome (obesity, a rounded face, increased fat): 4 people, 5.48%
Diabetes: 4 people, 5.48%
Spondylolisthesis (displacement of a vertebra or the vertebral column in relation to the vertebrae below): 3 people, 4.11%
Blood Pressure Abnormal: 2 people, 2.74%
Pain: 2 people, 2.74%

* Approximation only. Some reports may have incomplete information.

Do you take Signifor and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Signifor:

Signifor (887 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Signifor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,639 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pasireotide diaspartate (the active ingredients of Signifor) and Signifor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.